Learning from Disease Registries During a Pandemic: Moving Towards an International Federation of Patient Registries.
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Learning from Disease Registries During a Pandemic: Moving Towards an International Federation of Patient Registries.
Authors
Keywords
-
Journal
CLINICS IN DERMATOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-04-07
DOI
10.1016/j.clindermatol.2021.01.018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata
- (2020) Nekma Meah et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Development of an openEHR Template for COVID-19 Based on Clinical Guidelines
- (2020) Mengyang Li et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- International collaboration and rapid harmonization across dermatologic COVID-19 registries
- (2020) Esther E. Freeman et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Generic outcome set for the international registry on Laser trEAtments in Dermatology (LEAD): a protocol for a Delphi study to achieve consensus on what to measure
- (2020) Frederike Fransen et al. BMJ Open
- TRE atment of AT opic eczema ( TREAT ) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries
- (2019) F.M. Vermeulen et al. BRITISH JOURNAL OF DERMATOLOGY
- A Standardisation Approach to Compare Treatment Safety and Effectiveness Outcomes between Clinical Trials and Real World Populations in Psoriasis
- (2019) Z. Z. N. Yiu et al. BRITISH JOURNAL OF DERMATOLOGY
- Development of a pilot rare disease registry: a focus group study of initial steps towards the establishment of a rare disease ecosystem in Slovenia
- (2019) Dalibor Stanimirovic et al. Orphanet Journal of Rare Diseases
- Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)
- (2018) Xavier Kurz et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR
- (2018) Kayleigh J. Mason et al. JAMA Dermatology
- The International TREatment of ATopic Eczema (TREAT) Registry Taskforce: An Initiative to Harmonize Data Collection across National Atopic Eczema Photo- and Systemic Therapy Registries
- (2017) Phyllis I. Spuls et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries
- (2017) Louise A. A. Gerbens et al. Trials
- Linked Registries: Connecting Rare Diseases Patient Registries through a Semantic Web Layer
- (2017) Pedro Sernadela et al. Biomed Research International
- Review of patient registries in dermatology
- (2016) Gabriella DiMarco et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Establishment of a European Registry for hidradenitis suppurativa/acne inversa by using an open source software
- (2015) M. Daxhelet et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The British Association of Dermatologists’ Biologic Interventions Register (BADBIR): design, methodology and objectives
- (2012) A.D. Burden et al. BRITISH JOURNAL OF DERMATOLOGY
- Challenges for Synthesising Data in a Network of Registries for Systemic Psoriasis Therapies
- (2012) A.D. Ormerod et al. DERMATOLOGY
- Significance of Patient Registries for Dermatological Disorders
- (2012) Mark P. de Souza et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Use Of 13 Disease Registries In 5 Countries Demonstrates The Potential To Use Outcome Data To Improve Health Care’s Value
- (2011) Stefan Larsson et al. HEALTH AFFAIRS
- A registry of registries? The US backs the idea for patients
- (2011) Monica Heger NATURE MEDICINE
- Assessing Long-Term Drug Safety: Lessons (Re) Learned from Raptiva
- (2010) Nicole M. Seminara et al. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
- Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis
- (2008) C. Leonardi et al. BRITISH JOURNAL OF DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started